BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Lantibio Inc. 

100 Europa Drive, Suite 421

Chapel Hill  North Carolina  27517  U.S.A.
Phone: 919-960-0217 Fax: 919-929-3447


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Lantibio Inc. and TRB Chemedica Announce Licensing Agreement with Alcon Laboratories, Inc. (ACL) for US Development and Marketing of Dry Eye Drug 11/6/2007 7:37:18 AM    More...
AOP Orphan Pharmaceuticals AG and Lantibio Inc. Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy 3/7/2007 10:16:31 AM    More...
Lantibio Inc. And TRB Chemedica Announce Special Protocol Assessment-Endorsed Phase III Trial Initiation Of VISMED(R) For Dry Eye Syndrome 1/17/2007 8:50:02 AM    More...
Lantibio Inc. And TRB Chemedica Announce Agreement For US Development And Marketing Of VISMED(R) 1/12/2006 11:06:24 AM    More...
Lantibio Inc. Announces The Initiation Of Clinical Trials In Dry Eye Syndrome And The Company's Formation Of A Scientific Advisory Board 10/19/2005 5:13:01 PM    More...
AOP Orphan Pharmaceuticals And Lantibio, Inc. Announce A Licensing And Commercialization Agreement For Moli1901 In Cystic Fibrosis 10/19/2005 5:11:32 PM    More...
Lantibio Inc. And Apotex Fermentation Inc. Announce A Development, Supply And Royalty Agreement For Lantibio's Lead Compound 10/19/2005 5:09:09 PM    More...

//-->